IFN-γ、IL-4、TGF-β在诱导EAMG耐受中的作用

被引:1
|
作者
梁丽云 [1 ]
马存根 [1 ]
丰玲 [1 ]
机构
[1] 大同医学专科学校中心实验室!山西大同037008
关键词
实验性自身免疫性重症肌无力; 耐受; IFN-γ; IL-4; TGF-β;
D O I
10.13431/j.cnki.immunol.j.20000086
中图分类号
R746.1 [重症肌无力];
学科分类号
1002 ;
摘要
目的为探讨鼻腔耐受和 Wistar大鼠对 EAMG耐受的机制。方法用放射标记的 c DNA寡核苷酸作探针原位杂交计数免疫后第 7周表达 IFN-γ、IL - 4和 TGF-β m RNA的 MNC。结果 EAMG大鼠 PIL N和脾脏中 IFN-γ m RNA表达细胞数比 CFA大鼠高 (P<0 .0 5 ) ;鼻腔耐受大鼠 PIL N中 IFN-γ和 IL - 4m RNA表达细胞数比 EAMG大鼠低 ,PIL N、脾脏和胸腺中 TGF-β m RNA表达细胞数比 EAMG大鼠高 (P<0 .0 5 ) ;WF大鼠 PIL N中 IFN-γ m RNA表达细胞数比 EAMG大鼠低 ,TGF- β m RNA表达细胞数比 EAMG大鼠高 (P<0 .0 5 )。结论 IFΝ- γ表达增高与 EAMG发生有关 ,IFN- γ表达降低 TGF- β表达增高与 EAMG耐受有关 ;TGF- β表达增高在 EAMG耐受中起重要作用。
引用
收藏
页码:275 / 277
页数:3
相关论文
共 7 条
  • [1] BIESECKER G,KOFFLER D.Resistance to experimental autoimmune myasthenia gravis in genetically inbred rats: association with decreased amounts of in situ acetylcholine receptor antibody complexes. J Immunol . 1988
  • [2] WANG ZY,QIAO J,LINK H.Suppression of experimental autoimmune myasthenia gravis by oral admi nistration of acetylcholine receptor. J Neuroimmunol . 1993
  • [3] SIMMONS RD,WILLENBORG DO.Direct injection of cytokines into the spinal cord causes autoimmune encephalomyelitis-like inflammation. Journal of the Neurological Sciences . 1990
  • [4] MILLER A,LIDER O,ROBERTS AB,et al.Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor - after antigen-specific triggering. Proceedings of the National Academy of Sciences of the United States of America . 1992
  • [5] MUSTAFA MI,DIENER P,HOJEBERG B,et al.T cell immunity and interferon- secretion during experimental allergic encephalomyelitis in Lewis rats. J Neuroimmunol . 1991
  • [6] WANG ZY,LINK H,LJUNDAHL A,et al.Induction of interferon- , interleukin-4 and transforming growth factor - in rats orally tolerized against experimental autoimmune myasthenia gravis. Cellular Immunology . 1994
  • [7] MA CG,ZHANG GX,XIAO BG,et al.Suppression of experimental autoimmune myasthenia gravis by nasal administration of acetylcholine receptor. J Neuroimmunol . 1995